QSS
GMAB icon

Quantitative Systematic Strategies’s Genmab GMAB Stock Holding History

Quantitative Systematic Strategies’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,751
Closed -$600K – 664
2020
Q4 		$600K Sell
14,751
-11,743
-44% -$439K 0.08% 351
2020
Q3 		$970K Buy
26,494
+1,504
+6% +$54.4K 0.17% 180
2020
Q2 		$847K Buy
+24,990
New +$681K 0.17% 212

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Quantitative Systematic Strategies's GMAB Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of Genmab (GMAB) in Q1 2021, closing a stake of 14,751 shares — an estimated $600K sold.

Quantitative Systematic Strategies first reported a position in GMAB in Q2 2020 and held it in 3 quarters. The position peaked at $970K in Q3 2020. 209 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,751 Genmab shares in Q1 2021, an estimated $600K.
  • Quantitative Systematic Strategies first reported a position in Genmab in Q2 2020 and held it in 3 quarters.
  • Quantitative Systematic Strategies's Genmab position peaked at $970K in Q3 2020.
  • 209 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.